TNF and fibrosarcoma: Similar strategy was adopted by Jeon et al., when they described an EDB-targeting aptide fused to mouse TNF-α (mTNFα-APTEDB) for systemic and targeted therapy of EDB-overexpressing fibrosarcoma (Jeon et al., 2017).